Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan · Delayed Price · Currency is TWD 26.35
+0.10 (0.38%)
Sep 19, 2025, 9:49 AM CST
Bioray Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | 30.5 | 1 | -11.56 | 0.5 | -7.19 | -0.06 | Upgrade |
Depreciation & Amortization | 23.44 | 24.47 | 24.48 | 21.87 | 18.83 | 15.21 | Upgrade |
Other Amortization | 0.51 | 0.51 | 0.52 | 0.36 | 0.25 | 0.07 | Upgrade |
Loss (Gain) From Sale of Assets | 0.06 | 0.05 | -0.2 | -0.18 | - | 3.06 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 1.3 | - | - | - | Upgrade |
Stock-Based Compensation | - | - | - | 0.02 | - | - | Upgrade |
Provision & Write-off of Bad Debts | 0.3 | 0.44 | -0.01 | 0.08 | - | 0.31 | Upgrade |
Other Operating Activities | 8.67 | 1.79 | -0.27 | 1.8 | 1.62 | -8.21 | Upgrade |
Change in Accounts Receivable | -15.86 | -4.2 | -0.56 | -5.96 | -13.66 | 7.87 | Upgrade |
Change in Inventory | 1.44 | 9.18 | -4.12 | -6.44 | 2.82 | -12.62 | Upgrade |
Change in Accounts Payable | -5.53 | -4.96 | -3.15 | 1.21 | 4.75 | -0.42 | Upgrade |
Change in Unearned Revenue | -1.91 | 4.97 | -2.52 | -2.98 | 1.49 | -2.34 | Upgrade |
Change in Other Net Operating Assets | -8.08 | -16.6 | -4.67 | -7.8 | -0.07 | -1.19 | Upgrade |
Operating Cash Flow | 33.54 | 16.65 | -0.76 | 2.48 | 8.83 | 1.67 | Upgrade |
Operating Cash Flow Growth | 422.03% | - | - | -71.93% | 427.42% | -97.31% | Upgrade |
Capital Expenditures | -2.28 | -3.22 | -10.02 | -59.64 | -14.98 | -51 | Upgrade |
Sale of Property, Plant & Equipment | 30.42 | 50.56 | 0.2 | 0.36 | 0.55 | 0.08 | Upgrade |
Cash Acquisitions | - | - | -3.54 | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -0.08 | -0.08 | -0.16 | -0.75 | -0.56 | -0.38 | Upgrade |
Other Investing Activities | 6.14 | 6.46 | 0.97 | 0.39 | -4.8 | -1.6 | Upgrade |
Investing Cash Flow | 34.21 | 53.72 | -12.55 | -59.63 | -19.79 | -52.9 | Upgrade |
Short-Term Debt Issued | - | - | 10 | 15 | 15 | - | Upgrade |
Long-Term Debt Issued | - | 55 | - | - | - | - | Upgrade |
Total Debt Issued | 10 | 55 | 10 | 15 | 15 | - | Upgrade |
Short-Term Debt Repaid | - | - | -25 | -25 | -17.2 | - | Upgrade |
Long-Term Debt Repaid | - | -29.7 | -7.59 | -6.42 | -5.95 | -6.08 | Upgrade |
Total Debt Repaid | -55.9 | -29.7 | -32.59 | -31.42 | -23.15 | -6.08 | Upgrade |
Net Debt Issued (Repaid) | -45.9 | 25.3 | -22.59 | -16.42 | -8.15 | -6.08 | Upgrade |
Repurchase of Common Stock | -7.5 | -14.17 | - | - | - | - | Upgrade |
Common Dividends Paid | - | - | -6.02 | - | - | -8.02 | Upgrade |
Other Financing Activities | -0.01 | -0.32 | -0.13 | 86.34 | -0.48 | -1.23 | Upgrade |
Financing Cash Flow | -53.41 | 10.82 | -28.73 | 69.92 | -8.64 | -15.33 | Upgrade |
Foreign Exchange Rate Adjustments | - | - | 0 | -0.01 | 0.01 | -0.5 | Upgrade |
Net Cash Flow | 14.33 | 81.19 | -42.04 | 12.75 | -19.59 | -67.05 | Upgrade |
Free Cash Flow | 31.26 | 13.43 | -10.78 | -57.16 | -6.15 | -49.32 | Upgrade |
Free Cash Flow Margin | 13.59% | 6.66% | -5.62% | -29.99% | -4.15% | -31.56% | Upgrade |
Free Cash Flow Per Share | 1.06 | 0.45 | -0.36 | -2.04 | -0.23 | -1.84 | Upgrade |
Cash Interest Paid | 0.32 | 0.32 | 0.13 | 0.33 | 0.95 | 1.17 | Upgrade |
Cash Income Tax Paid | - | -0.2 | 0.03 | -1.17 | 0.36 | 7.99 | Upgrade |
Levered Free Cash Flow | 46.21 | 7.72 | -12.81 | -60.67 | -5.78 | -54.3 | Upgrade |
Unlevered Free Cash Flow | 46.7 | 8.55 | -11.98 | -59.81 | -5.18 | -53.57 | Upgrade |
Change in Working Capital | -29.94 | -11.61 | -15.02 | -21.97 | -4.68 | -8.7 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.